Cytosolic autoantigens in lymphocytic hypophysitis

Area of Science:

• Endocrinology
• Immunology
• Autoimmune Diseases

Background:

• Lymphocytic hypophysitis diagnosis is challenging, historically relying on postmortem or biopsy confirmation.
• Traditional immunofluorescence for detecting antipituitary autoantibodies lacks specificity and antigen identification.
• Immunoblotting offers enhanced specificity and molecular weight identification of autoantigens.

Purpose of the Study:

• To evaluate the utility of immunoblotting for detecting antipituitary autoantibodies in various patient cohorts.
• To identify specific autoantigens targeted in lymphocytic hypophysitis and related conditions.
• To compare autoantibody prevalence between biopsy-proven hypophysitis, suspected cases, and other autoimmune diseases.

Main Methods:

• Sera from 115 patients and 52 normal subjects were analyzed using immunoblotting.
• Pituitary cytosolic proteins from human autopsy samples were used as antigens.
• Patient groups included biopsy-proven hypophysitis, suspected hypophysitis, pituitary tumors, Hashimoto's, Graves', Addison's diseases, rheumatoid arthritis, and controls.

Main Results:

• Antipituitary autoantibodies targeting a 49-kDa protein were found in 70% of biopsy-proven hypophysitis cases.
• Reactivity to the 49-kDa protein was also observed in suspected hypophysitis (55%) and Addison's disease (42%).
• A 40-kDa autoantigen was identified in 50% of biopsy-proven hypophysitis patients; both antigens are conserved and not pituitary-exclusive.

Conclusions:

• Immunoblotting is a valuable tool for identifying antipituitary autoantibodies in lymphocytic hypophysitis.
• The 49-kDa and 40-kDa cytosolic proteins represent significant autoantigens in hypophysitis.
• These findings aid in understanding the immunopathology of lymphocytic hypophysitis and related autoimmune disorders.